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undesirable developmental effects in human fetuses and children (1) . These effects include impaired neurobehavioral development and other possible effects on early development and growth.
Currently the only orally administered treatment for lead poisoning is meso-2,3-dimercaptosuccinic acid (meso-DMSA), which is available commercially as Succimer (Chemet, Bock Pharmacal Co., St. Louis, MO). This compound was approved by the Food and Drug Administration in 1991 for treatment of childhood lead intoxication when blood lead levels exceed 45 g/dl. Since that time, there has been an increasing use of meso-DMSA for the treatment of children with blood lead levels as low as 20 pg/dl ().
Despite its increasing clinical use, meso-DMSA has several disadvantages. It is virtually insoluble in acidic solution and only slightly soluble in water. These properties may reduce the gastrointestinal absorption of the drug and result in the need for a comparatively higher dose of meso-DMSA to maintain an effective blood level for chelation therapy. In fact, studies have found that only 20.6% of the administered dose of meso-DMSA is found in the urine as total meso-DMSA 14 hr after the drug is given orally (3, 4) . In addition, two unpublished bioavailability studies conducted at McNeil Laboratories indicate that the oral bioavailability of the commercial meso-DMSA formula was only about 25% (5) . Another disadvantage of meso-DMSA is that it reportedly removes lead only from the extracellular fluid of plasma (6) , and thus it may be unable to mobilize lead from within the brain, bone marrow, or other soft tissues where lead can deposit.
DMSA exists in two diastereoisomeric forms, meso and racemic (dl-). The dl-DMSA form is soluble in water, strongly acidic solutions, and in nonaqueous solvents such as ethyl ether (7) . On this basis it was proposed that dl-DMSA will be absorbed across the intestinal epithelium more efficiently than the meso diastereoisomer upon oral administration and that it may be a more effective chelator for the treatment of lead poisoning (8) .
The efficacy of dI-DMSA in the treatment of lead poisoning has not been studied in either human subjects or animals. However, in vivo studies with dl-DMSA showed that it was more effective than mesa-DMSA in reducing mortality and increasing the excretion of mercury and cadmium from the body in cases of acute poisoning (9) (10) (11) . The results of these in vivo studies with mercury and cadmium have been rationalized recently on the basis of higher formation constants for the complexes of dl-DMSA with cadmium and mercury at physiological pH (1X.
To help determine whether dl-DMSA might be more effective than meso-DMSA in the treatment of lead poisoning, we used the Caco-2 monolayer cell culture model to elucidate the comparative epithelial transfer of the two forms of DMSA. The suitability of this model for elucidating the transport pathways of a wide variety of molecules, including peptides, proteins, and metals (e.g., calcium and cadmium), is well established (13, 14) . The advantages of this model include 1) rapid assessment of absorption and metabolism of molecules, 2) independent access to both the apical (AP) and basolateral (BL) sides of the cell monolayer to permit monitoring both the appearance and disappearance of solutes, 3) the use of human cells as opposed to tissues from animal sources, 4) greater cell viability compared with isolated or perfused systems, and 5) better reproducibility (15) . Recent studies (15) (16) (17) have shown good correlation between data from this model and other well-established in vitro and in situ models traditionally used for conducting such absorption studies (16, 18) .
The uptake and internalization of lead has been shown to mimic that of calcium in chick and bovine intestinal cells (19) . Calcium uptake involves an initial internalization step followed by intracellular binding to calcium-binding protein (CaBP) (20) (19) .
A micro-proton-induced X-ray emission (micro-PIXE) technique (21) was used to assess the uptake of lead by the Caco-2 cells. This was accomplished by measuring the concentrations of lead, zinc, and other essential elements in cells exposed to lead solutions. The relative ability of the two forms of DMSA to mobilize lead, zinc, and other essential elements from inside the cells was assessed using macro-PIXE (22) . This technique provides information on the concentrations of elements above atomic number 11 and is the only analytical method that can measure 20-30 elements nondestructively in a single small sample (<5 mg) with a detection limit of 1-5 ppm (dry weight).
The goal of the present study was to examine the behavior of the two isomers of DMSA in a tissue culture model by using PIXE to quantitate lead within cells treated with both lead and dl-or meso-DMSA. In addition to quantitative assessment of lead in the Caco-2 cells, micro-PIXE was used to qualitatively assess the location of lead within the cells.
Materials and Methods
Cell culture. Caco-2 cells (American Type Culture Collection, Rockville, MD) were cultured in T-75 flasks as described previously (15) . The protocol for seeding the cells in Transwell cell culture inserts (Costar, Cambridge, MA) was as described earlier (15), with the following modifications. The 12-well tissue culture dusters were prepared in the laminar flow hood by pipetting 1.5 ml of complete medium (38°C) into each well. A Transwell insert was placed in each well using a pair of sterile forceps. Aliquots of a 7 x 104 cell suspension (0.5 ml) were then pipetted into the apical chamber of each Transwell insert, and the plates were transferred to the incubator.
Cell viability studies. Before the lead uptake and DMSA transport experiments, we conducted cytotoxicity assays to ensure that the viability of the cells was not compromised in the presence of the experimental compounds at the concentrations to be tested. This was accomplished by comparing the amount of lactate dehydrogenase (LDH; assay kit DG1340K, Sigma, St. Louis, MO) released by the cells after treatment with a range of concentrations of lead or the DMSA diastereoisomers with the amount of LDH released by a control exposed to serum-free medium. LDH, an enzyme released from within a cell when it dies, is a good indicator of the damage to a population of cells caused by experimental treatment. The toxicities of vitamin D3 and Nethylmaleimide (NEM) were determined in previous studies involving Caco-2 cells (23), and the experimental concentrations from these previous experiments were adopted.for the present study.
The cytotoxicity studies were performed in 96-well tissue culture plates (Falcon/Becton Dickinson Labware, Lincoln Park, NJ). For the transport studies, eight-well strip tissue culture inserts (Nalge-Nunc International, Naperville, IL; miniature Transwells) were used to mimic the conditions of the actual experiment. The cells were seeded (4 x To initiate the uptake experiments, the medium was aspirated from the wells and replaced with 2 ml of SFM containing 500 pM lead. After 30 min of exposure to the lead, the SFM was removed and the cell layers gently rinsed once with SFM. Following the rinsing step, the treatments were added to the wells. A treatment group consisted of three wells. The four treatment groups were 1) 500 pM lead only, 2) cells pretreated with 100 nM vitamin D3, then 500 pM lead, 3) cells pretreated with 500 pM NEM, then 500 pM lead, and 4) cells pretreated with both vitamin D (100 nM) and NEM (500 pM), followed by exposure to 500 pM lead.
After 30 min of exposure to the 500 pM lead, the cells were gently rinsed with SFM. Forceps were used to remove the cover slips from the wells. The cover slips, with their attached cell layer, were then coated by dipping them into a water bath on the surface of which had been floated a thin layer of carbon. The carbon layer was necessary to disperse charge throughout the samples and thereby reduce background. The coated samples were placed in a vacuum chamber attached to the micro-PIXE apparatus and allowed to dry overnight. Cells were examined visually using light microscopy to position them directly in the path of the micro-PIXE beam. The cells were then subjected to analysis by micro-PIXE and the resulting images stored on computer disk for future examination.
Chelation ofleadfrom the Caco-2 cells by the DMSA diareoisomers. We assessed the comparative chelating ability of the two DMSA diastereoisomers by first exposing a flask of cells to 500 pM lead for 30 min. The lead-containing medium was then aspirated and the cells were rinsed once with SFM. After rinsing, 10 ml of SFM alone, or SFM containing 50 pM meso-DMSA or 50 pM dl-DMSA was added to each flask. After 15 min of exposure to the DMSA diastereoisomers, the cell monolayers from each experiment were washed once with SFM alone and then with a 1 x trypsin-EDTA solution to chelate any remaining extracellular lead and to remove the cells from the substrate. After 8-10 min of trypsinization, the cells were scraped from the substrate with a cell lifter and centrifuged (Model TJ-6, Beckman Instruments) for 10 min at 400g. The supernatant was then aspirated. The resulting cell pellet was transferred by pipet to a round piece of filter paper (6 mm in diameter) that had been placed on a piece of mylar (2.5 pm) stretched over an X-ray fluorescence cup (3.2 cm in diameter; Chemplex Industries, Tuckahoe, NY). The pellet was allowed to dry overnight and was then covered with another sheet of mylar. This preparation was then analyzed using macro-PIXE. To normalize the data for possible differences in cell density, we measured the lead-to-iron ratio for each treatment group. Transport of the DMSA diastereoisomers across the Caco-2 monolayer. Caco-2 cells were routinely seeded into Transwell 12-well plate inserts as described previously (15) . To initiate the experiments, the AP fluid was replaced with transport buffer alone (Hanks' Balanced Salt Solution with 5.6 mM glucose and 20 mM HEPES, pH 7.2, 38°C), or transport buffer containing 50 pM meso-or dl-DMSA. The basolateral medium was replaced with transport buffer. After 15 min of exposure to the DMSA diastereoisomers, medium from the basolateral chamber was sampled. The samples were directly transferred to test tubes and assayed spectrophotometrically for DMSA content using Ellman's reagent (24) to quantitate the amount of DMSA transported across the monolayer.
Results and Discussion
Cell viability studies. The maximum DMSA concentration tolerated by the Caco-2 cell monolayer, without significant cell death (determined by LDH release), when compared with the control, was 50 pM for meso-DMSA and between 25 and 50 pM for db DMSA (data not shown). This is consistent with the findings of Aposhian and Aposhian (6), who found dl-DMSA to have a lower LD50 than meso-DMSA in mice.
Optimization of lead concentrations and exposure times. The optimum lead concentration and exposure time was 500 pM for 30 min. These conditions resulted in the least amount of cell death and the highest cellular lead concentrations (see Table 1 ). The magnitude of the cellular lead concentration was an important consideration for the study, due to the fact that it was difficult to quantitatively assay low lead concentrations with macro-PIXE. Quantitating lead in small samples (<5 mg) proved to be problematic. Initial attempts to measure lead in cells collected from a 12-well tissue culture plate were unsuccessful, and we decided to use an entire flask of cells for each trial in order to concentrate the amount of lead that would be in the path of the macro-PIXE beam.
Micro-PIXE visualization of the uptake oflead by the Caco-2 cells. After 30 min of exposure to 500 pM lead, the cell membrane contained a much higher concentration of lead than the cell interior or the surrounding fluid, as can be seen in the light microscopy and micro-PIXE image (Fig. IA  and B, respectively) . Lead levels in the cells that were pretreated with vitamin D3 appear, by visual inspection, to be higher than those of the control (lead only) group ( Fig. 2A and B) . These data suggest that vitamin D3 enhanced the uptake of lead by the Caco-2 cells, although the lead concentration cannot be quantitated accurately. Transport of dl-and meso-DMSA across the Caco-2 monolayer. Fang et al. (12) hypothesized, based upon its higher solubility in gastric fluids and its more lipophiic nature, that the dl-DMSA would more readily penetrate the cell membrane and therefore the intestinal epithelium. In fact, significantly larger amounts of 50 pM dl-DMSA were transported across the monolayer in comparison to the meso-DMSA (Fig. 5) . The amount of meso-DMSA transported across the monolayer was not significantly different from background. These findings are consistent with the predictions pertaining to the relative lipophilicity of dl-DMSA compared with that of meso-DMSA made by Fang and Fernando (8 
